Transaction in Own Shares

Summary by AI BETAClose X

On October 3, 2025, GSK plc, acting through BNP Paribas SA, purchased 350,000 of its own ordinary shares with a nominal value of 31¼ pence each. The shares were bought at prices ranging from 1,598.00p to 1,649.00p, with a volume-weighted average price of 1,631.45p per share. These shares will be held as treasury shares as part of the company's existing buyback program announced on September 30, 2025. Since September 30, 2025, GSK has purchased a total of 1,252,000 ordinary shares. Following this transaction, GSK will hold 248,716,844 ordinary shares in treasury, with 4,066,691,695 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to treasury shares is 6.12 percent. The total number of voting rights in the company is 4,066,691,695.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings